CASTRICONI, ROBERTA
 Distribuzione geografica
Continente #
EU - Europa 6.899
Totale 6.899
Nazione #
IT - Italia 6.899
Totale 6.899
Città #
Genova 5.089
Rapallo 666
Genoa 614
Vado Ligure 506
Bordighera 24
Totale 6.899
Nome #
PVR(CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis 189
PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance 184
NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27 168
Both CD133(+) and CD133(-) medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK-mediated cytotoxicity 157
Natural Killer Cells and Neuroblastoma: Tumor Recognition, Escape Mechanisms, and Possible Novel Immunotherapeutic Approaches. 152
Main NK cell receptors and their ligands: regulation by microRNAs 143
Identification of NKp80, a novel triggering molecule expressed by human NK cells. 142
Human NK cell infusions prolong survival of metastatic human neuroblastoma-bearing NOD/scid mice. 134
Analysis of the molecular mechanism involved in 2B4-mediated NK cell activation: evidence that human 2B4 is physically and functionally associated with the linker for activation of T cells 130
Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells 128
Function and specificity of human natural killer cell receptors. 127
Pathogen-induced private conversations between natural killer and dendritic cells 126
M-CSF induces the expression of a membrane-bound form of IL-18 in a subset of human monocytes differentiating in vitro toward macrophages 126
Human NK cells and NK receptors 120
Natural killer lymphocytes: "null cells" no more. 120
Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors 119
CIS is a negative regulator of IL-15-mediated signals in NK cells 119
Molecular mechanisms directing migration and retention of natural killer cells in human tissues 119
The leukocyte Ig-like receptor (LIR)-1 for the Cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles: analysis of LIR-1+ NK cell clones 118
Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction 118
The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes. 118
NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy? 118
Soluble HLA-G dampens CD94/NKG2A expression and function and differentially modulates chemotaxis and cytokine and chemokine secretion in CD56bright and CD56dim NK cells. 117
Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines 115
Cellular ligands for activating NK receptors 114
PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance 111
Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. 111
Small round blue cell tumours: diagnostic and prognostic usefulness of the expression of B7-H3 surface molecule. 109
Immunotherapy in the Treatment of Human Solid Tumors: Basic and Translational Aspects 109
CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity 108
TLR activation of tumor-associated macrophages from ovarian cancer patients triggers cytolytic activity of NK cells. 108
Neuroblastoma-Derived TGF-beta1 Modulates the Chemokine Receptor Repertoire of Human Resting NK Cells. 106
Shaping of adaptive immunity by innate interactions 106
NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. 105
Neuroblastoma-derived transforming growth factor (TGF) β1 modulates the chemokine receptor repertoire of human resting Natural Killer Cells. 105
Expression of the DNAM-1 ligands Nectin-2 (CD112) and poliovirus receptor (CD155) on dendritic cells: relevance for natural killer/dendritic cells interaction 105
Cell-laden hydrogel as a clinical-relevant 3D model for analyzing neuroblastoma growth, immunophenotype, and susceptibility to therapies 105
New perspectives in glioma immunotherapy. 104
Novel Immunoregulatory Functions of IL-18, an Accomplice of TGF-β1 103
Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences on the NK-mediated killing of dendritic cells 102
Overview of the Soluble and Membrane-bound Tumor Factors Limiting NKmediated Immune Surveillance 101
Imatinib and nilotinib off-target effects on human NK cells, monocytes, and M2 macrophages 101
Neuroblastoma Cells Modulate Chemokine Receptor Repertoire of Resting NK Cells 99
Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule 97
The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition 95
Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin 93
Updated clinical and biological information from the two-stage phase II study of imatinib mesylate in subjects with relapsed/refractory neuroblastoma 93
Cytokine-induced expression of killer inhibitory receptors in human T lymphocytes 92
TGF-beta1 downregulates the expression of CX3CR1 by inducing miR-27a-5p in primary human NK cells 89
The SIICA School of Immunology 2017: a gathering for NGS (next generation scientists) 85
Su.64. Natural Killer Cell-mediated Recognition of Human Brain Tumors 85
Functional characterization of natural killer cells in type I leukocyte adhesion deficiency 83
Identification of a novel neuroblastoma-associated molecule that protects from NK-mediated lysis 82
Selective cross-talk among natural cytotoxicity receptors in human natural killers cells 79
Therapeutic and diagnostic methods and compositions targeting 4IG-B7-H3 and its counterpart NK cell receptor 79
Identification of 4Ig-B7-H3 as a novel neuroblastoma-associated molecule that exerts a protective role from natural killer cell-mediated lysis 79
Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes (LDGL) 73
Natural Killer cells recognize and kill human glioblastoma cells with stem cell-like properties 71
TGFβ1 inhibits the surface expression of the NKp30 and NKG2D triggering NK receptors: consequences for the NK-mediated killing of dendritic cells 70
ISTOLOGIA di Monesi 7 67
Soluble HLA-G dampens CD94/NKG2A expression and function and differentially modulates chemotaxis and cytokine /chemokine secretion in CD56(bright) and CD56(dim) NK cells 55
Surface NK receptors and their ligands on tumors cells 53
Elementi di istologia e cenni di embriologia 52
Tumor Microenvironment and Hydrogel-Based 3D Cancer Models for In Vitro Testing Immunotherapies 48
Inhibitory axes impacting on the activity and fate of Innate Lymphoid Cells 45
Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants 44
NK Cell Function Regulation by TGF-β-Induced Epigenetic Mechanisms 42
A multi-organ-on-chip to recapitulate the infiltration and the cytotoxic activity of circulating NK cells in 3D matrix-based tumor model 33
Strategies for Potentiating NK-Mediated Neuroblastoma Surveillance in Autologous or HLA-Haploidentical Hematopoietic Stem Cell Transplants 26
B7-H3 in Pediatric Tumors: Far beyond Neuroblastoma 23
Monocyte and Macrophage in Neuroblastoma: Blocking Their Pro-Tumoral Functions and Strengthening Their Crosstalk with Natural Killer Cells 17
miR-24-3p down-regulates the expression of the apoptotic factors FasL and BIM in human natural killer cells 12
Editorial: Recent 3D Tumor Models for Testing Immune-Mediated Therapies 12
Editorial: TGF-β as a Key Regulator of NK and ILCs Development and Functions 10
High-dimensional single-cell analysis of human natural killer cell heterogeneity 8
Totale 7.111
Categoria #
all - tutte 22.045
article - articoli 21.144
book - libri 416
conference - conferenze 232
curatela - curatele 0
other - altro 0
patent - brevetti 151
selected - selezionate 0
volume - volumi 102
Totale 44.090


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.485 0 0 0 0 167 206 267 128 163 312 185 57
2020/2021580 32 70 65 38 27 84 15 49 44 76 29 51
2021/2022852 34 79 66 113 14 53 43 201 38 70 39 102
2022/2023820 81 72 11 85 126 144 3 60 147 6 69 16
2023/2024489 22 69 15 78 29 52 27 38 33 23 43 60
2024/2025514 25 103 84 91 211 0 0 0 0 0 0 0
Totale 7.111